FDA Determines Regulatory Review Period for Aqueous Aryl Fluorophosphite Suspension Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for Aqueous Aryl Fluorophosphite Suspension, a food additive, in order to extend the patent that governs it, as required by law.